Navigation Links
Nektar's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
Date:5/12/2008

de(TM), a novel, synthetic, peptide-based erythropoiesis-stimulating agent (ESA), is a product candidate that has demonstrated the ability to stimulate the production of red blood cells. If proven safe and effective in clinical trials, it may offer physicians and patients an alternative therapy to recombinant erythropoietin, a hormone that stimulates red blood cell formation.

Affymax and Takeda are collaborating on the development of Hematide(TM). The product will be commercialized in the European Union by Takeda. Affymax is conducting Phase 3 clinical trials for Hematide(TM) to treat anemia in chronic renal failure indications. Takeda is also focusing on a recently initiated Phase 1 clinical trial to evaluate Hematide(TM) to treat chemotherapy-induced anemia in prostate, breast and non-small cell lung cancer patients. Hematide(TM) is a trademark of Affymax.

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development technology platforms. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.

This press release contains forward-looking statements regarding the potential of Hematide(TM), the potential of Nektar's PEGylation Technology, and the overall prospects for Nektar's business. These forward-looking statements involve important risks and uncertainties, including but not limited to: (i) because Hematide(TM) is still in clinical development, the risk of failure is high and can occur at any stage due to many factors including but not limited to safety and efficacy considerations; (ii) Takeda and Affymax may fail to obtain regulatory approval for Hematide(TM) in one or more indications; (iii) if Hematide(TM) does receive regulatory approval, Nektar's actua
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmasset Selected to Join the NASDAQ Biotechnology Index
2. USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical
3. QLT reports initial proof of concept data for punctal plug delivery technology
4. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Entrust Chairman, President and CEO Bill Conner to Present at 8th Annual State of Technology Luncheon
7. Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development
8. Guided Surgery Technology Gaining Popularity in the Dental Implant Market
9. Genetic Engineering and Biotechnology News (GEN) Reports on Early ADMET Use
10. eResearchTechnology Reports First Quarter 2008 Results
11. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell Lindgren ... month on his first mission to the International Space ... 8 to 9 a.m. EDT Tuesday, July 7. ... Star City, Russia . The interviews will ... Television highlighting his mission training. To schedule an ...
(Date:6/30/2015)... -- Today, Americord Registry, one of the fastest growing cord blood ... partner at Kirkland & Ellis LLP, as the newest member ... http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are thrilled about Andrew ... Smithmyer , CEO of Americord. "He brings a wealth of ... Americord,s growth and vision." Andrew Horne ...
(Date:6/30/2015)... ... June 30, 2015 , ... With its latest polyacrylonitrile ... to achieve faster flow rates in comparison to nylon or polyethersulfone (PES). ... to allow easy liquid flow while trapping particulates as small as 0.2 micron ...
(Date:6/30/2015)... ... 30, 2015 , ... The maximum number of shares proposed to be purchased ... shares of unvested restricted stock). On June 29, 2015, the last trading day prior ... reported on the OTCBB was $2.29 per share. , The tender offer will expire ...
Breaking Biology Technology:NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2Americord Registry Announces Andrew Horne as Advisory Board Member 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3
... saliva can be used to quickly and effectively screen for ... children, says research in the June 2 issue of the ... at the University of Alabama at Birmingham (UAB) found saliva ... samples were used, and 97.4 percent of babies when the ...
... curtain about to rise on a much-anticipated new era of ... for food, fuel, and other uses scientists are reporting a ... corn, tomatoes, rice and other food crops. Their article appears ... Jorge Gardea-Torresdey and colleagues at The University of Texas ...
... 2011 VWR International, LLC, a global leader ... that it acquired the business of BioExpress Corp. ... in 1985, BioExpress is a well-respected distributor in ... offers over 200 well-known, multi-national brands, including its ...
Cached Biology Technology:Saliva is effective in screening for CMV infection in newborns, says NIH-funded research 2Saliva is effective in screening for CMV infection in newborns, says NIH-funded research 3VWR International, LLC Acquires BioExpress Corp. 2
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market announces that ... featured segment on "Money on the Mark", scheduled to air ... June 20 th . The ... be from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... of cholesterol is necessary for the formation of brain ... university Karolinska Institutet. The results, which are published in ... scientists to cultivate dopamine-producing cells outside the body. ... and demonstrates that the formation of dopamine-producing neurons during ...
... The United Kingdom and Singapore are focussing on innovative ... collaboration between the two countries in the water industry. ... are meeting today to share the latest in water ... the strategic area of water security. Gracing ...
... The study , Over a period of two years, ... of Copenhagen, have investigated physiological, sociological and psychological aspects ... adult premenopausal women have participated in the study. , ... randomly divided into three groups: One soccer group, one ...
Cached Biology News:Nanyang Technological University and UK partners heightens cooperation in water industry 2Nanyang Technological University and UK partners heightens cooperation in water industry 3Women's soccer -- get fit while having fun 2Women's soccer -- get fit while having fun 3
... generation bulk reagent dispenser offering unrivalled level ... and biotech laboratories. Based on the proven ... has been designed for effortless high speed ... multiple plate types including 1536. Through the ...
Multidrop DW is a high-speed automated dispenser for Deep Well plates, 1.1 ml test tubes and 96-well plates. Designed for accuracy and precision, the Multidrop DW dispenses up to eight different reag...
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
...
Biology Products: